Victory Capital Management Inc Kura Oncology, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$11.23 - $16.9 $1.81 Million - $2.73 Million	161,429 Added 11.89%	1,519,327 $18.9 Million
Q3 2022 Nov 02, 2022	BUY	$12.01 - $19.45 $7.1 Million - $11.5 Million	591,580 Added 77.2%	1,357,898 $18.5 Million
Q2 2022 Aug 01, 2022	BUY	$10.71 - $18.33 $8.21 Million - $14 Million	766,318 New	766,318 $14 Million
Q3 2021 Nov 02, 2021	SELL	$15.42 - $21.72 $1.09 Million - $1.53 Million	-70,540 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$20.85 - $29.88 $33.4 Million - $47.8 Million	-1,601,034 Reduced 95.78%	70,540 $1.47 Million
Q1 2021 May 04, 2021	BUY	$24.75 - $39.14 $3.5 Million - $5.53 Million	141,324 Added 9.24%	1,671,574 $47.3 Million
Q4 2020 Feb 01, 2021	SELL	$29.0 - $41.62 $5.03 Million - $7.22 Million	-173,429 Reduced 10.18%	1,530,250 $50 Million
Q3 2020 Nov 09, 2020	SELL	$16.3 - $30.64 $5.34 Million - $10 Million	-327,471 Reduced 16.12%	1,703,679 $52.2 Million
Q2 2020 Aug 07, 2020	SELL	$7.95 - $18.81 $4.62 Million - $10.9 Million	-581,669 Reduced 22.26%	2,031,150 $33.1 Million
Q1 2020 May 04, 2020	BUY	$6.45 - $14.04 $1.54 Million - $3.34 Million	238,233 Added 10.03%	2,612,819 $26 Million
Q4 2019 Feb 06, 2020	SELL	$12.97 - $15.94 $142,864 - $175,579	-11,015 Reduced 0.46%	2,374,586 $32.7 Million
Q4 2019 Feb 04, 2020	BUY	$12.97 - $15.94 $1.54 Million - $1.9 Million	118,985 Added 5.25%	2,385,601 $28 Million
Q3 2019 Nov 12, 2019	BUY	$14.75 - $20.87 $4.42 Million - $6.25 Million	299,346 Added 15.22%	2,266,616 $34.4 Million
Q2 2019 Aug 15, 2019	BUY	$14.71 - $19.79 $3.1 Million - $4.17 Million	210,900 Added 12.01%	1,967,270 $38.7 Million
Q1 2019 May 03, 2019	BUY	$13.73 - $16.87 $880,779 - $1.08 Million	64,150 Added 3.79%	1,756,370 $29.1 Million
Q4 2018 Feb 05, 2019	BUY	$10.6 - $17.49 $1.65 Million - $2.73 Million	155,910 Added 10.15%	1,692,220 $23.8 Million
Q3 2018 Nov 01, 2018	BUY	$16.65 - $21.85 $783,715 - $1.03 Million	47,070 Added 3.16%	1,536,310 $26.9 Million
Q2 2018 Aug 02, 2018	BUY	$14.8 - $18.8 $22 Million - $28 Million	1,489,240 New	1,489,240 $27.1 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$69 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.8 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$52.3 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.8 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$39 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account